GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Additional Paid-In Capital

Samsung BioLogics Co (XKRX:207940) Additional Paid-In Capital : ₩5,663,111 Mil(As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Additional Paid-In Capital?


Samsung BioLogics Co's quarterly additional paid-in capital stayed the same from Jun. 2023 (₩5,663,111 Mil) to Sep. 2023 (₩5,663,111 Mil) and stayed the same from Sep. 2023 (₩5,663,111 Mil) to Dec. 2023 (₩5,663,111 Mil).

Samsung BioLogics Co's annual additional paid-in capital increased from Dec. 2021 (₩2,487,313 Mil) to Dec. 2022 (₩5,663,111 Mil) but then stayed the same from Dec. 2022 (₩5,663,111 Mil) to Dec. 2023 (₩5,663,111 Mil).


Samsung BioLogics Co Additional Paid-In Capital Historical Data

The historical data trend for Samsung BioLogics Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Additional Paid-In Capital Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,487,313.08 2,487,313.08 2,487,313.08 5,663,111.35 5,663,111.35

Samsung BioLogics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,663,111.35 5,663,111.35 5,663,111.35 5,663,111.35 5,663,111.35

Samsung BioLogics Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Samsung BioLogics Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines